2022
DOI: 10.1016/j.drudis.2021.11.009
|View full text |Cite
|
Sign up to set email alerts
|

The global hearing therapeutic pipeline: 2021

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 66 publications
0
8
0
1
Order By: Relevance
“…In this way, the model can help to diagnose a hidden hearing loss and possibly also distinguish between its main causes, which is imperative in predicting the viability of implantation with a cochlear implant (Shearer and Hansen 2019) Due to its sufficiently detailed level of description, the model is also able to determine the effect of new mutations in genes responsible for hearing loss (Dror and Avraham 2010). In addition, in conjunction with experimental measurements, the model can serve as a tool to evaluate the effect of potential drugs targeting deafness (Isherwood et al 2022). Finally, a straightforward application of the model lies in the investigation of the functionality of cochlear implants.…”
Section: Discussionmentioning
confidence: 99%
“…In this way, the model can help to diagnose a hidden hearing loss and possibly also distinguish between its main causes, which is imperative in predicting the viability of implantation with a cochlear implant (Shearer and Hansen 2019) Due to its sufficiently detailed level of description, the model is also able to determine the effect of new mutations in genes responsible for hearing loss (Dror and Avraham 2010). In addition, in conjunction with experimental measurements, the model can serve as a tool to evaluate the effect of potential drugs targeting deafness (Isherwood et al 2022). Finally, a straightforward application of the model lies in the investigation of the functionality of cochlear implants.…”
Section: Discussionmentioning
confidence: 99%
“…A better understanding of aspects of hearing impairment, as captured by a ‘deep phenotype’ of hearing loss, may reveal essential biomarkers desperately needed in advancing treatment [ 51 , 52 ]. We see this as a necessary step between understanding what is happening in the cochlea at a fundamental level and how it translates to a more functional level, captured by biomarkers or auditory profiles [ 50 , 52 ], ultimately leading to our ability to understand speech-in-noise.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the categorization and identification of the site-of-lesion is important for patient selection for upcoming trials [ 51 , 52 ]. A deep auditory phenotype, possibly combined with a clear genotype when considering new forms of gene therapy, is thus essential for patient selection and for evaluation of inner ear therapeutic studies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…PedmarkTM (a sodium thiosulfate incorporating drug, effective in CIHL), Sonsuvi (an anti‐inflammatory and antiapoptotic drug effective for idiopathic SNHL), STR001 (an antioxidant effective in SSHL), and Otividex (a nuclear steroid receptor target, effective in Meniere's disease) are current treatments in phase 3 trials. [ 26 ]…”
Section: Current Technologies For the Treatment Of Hearing Lossmentioning
confidence: 99%